G65C (p.Gly65Cys) variant of AQP5 (Aquaporin-5)

G65C (p.Gly65Cys) in AQP5 (Aquaporin-5) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes population frequency data and structural context.

G65C (p.Gly65Cys) variant details